From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market...

Full description

Bibliographic Details
Main Authors: Daniela Luvero, Salvatore Lopez, Giorgio Bogani, Francesco Raspagliesi, Roberto Angioli
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Vaccines
Subjects:
HPV
cervical cancer
vaccine
immunotherapy
Online Access:https://www.mdpi.com/2076-393X/8/4/597

Similar Items

Similar Items